GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T80.82XD
Complication of immune effector cellular therapy, subsequent encounter
ICD10CM code
Similar Codes
ICD10CM codes
T80.82XD
- Complication of immune effector cellular therapy, subsequent encounter
T80.82XA
- Complication of immune effector cellular therapy, initial encounter
T80.82
- Complication of immune effector cellular therapy
T80.82XS
- Complication of immune effector cellular therapy, sequela
T80.89XD
- Other complications following infusion, transfusion and therapeutic injection, subsequent encounter
T80.90XD
- Unspecified complication following infusion and therapeutic injection, subsequent encounter
T80.8XXD
- Other complications following infusion, transfusion and therapeutic injection, subsequent encounter
T80.9XXD
- Unspecified complication following infusion, transfusion and therapeutic injection, subsequent encou
T80.6XXD
- Other serum reactions, subsequent encounter
T80.29XD
- Infection following other infusion, transfusion and therapeutic injection, subsequent encounter
HCPCS codes
S9359
- Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
J9311
- Injection, rituximab 10 mg and hyaluronidase
J7599
- Immunosuppressive drug, not otherwise classified
S9338
- Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care
J0850
- Injection, cytomegalovirus immune globulin intravenous (human), per vial
Q2043
- Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
G8482
- Influenza immunization administered or previously received
G9416
- Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the
J9227
- Injection, isatuximab-irfc, 10 mg
J9312
- Injection, rituximab, 10 mg
CPT4 codes
86849
- Unlisted immunology procedure
86153
- Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating t
38242
- Allogeneic lymphocyte infusions
88230
- Tissue culture for non-neoplastic disorders; lymphocyte
95199
- Unlisted allergy/clinical immunologic service or procedure
86644
- Antibody; cytomegalovirus (CMV)
90399
- Unlisted immune globulin
88239
- Tissue culture for neoplastic disorders; solid tumor
0538T
- Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for tra
36515
- Therapeutic apheresis; with extracorporeal immunoadsorption and plasma reinfusion